The catalyst recycling in the conversion of CO2 into formate using the iridium complex with 4,7-dihydroxy-1,10-phenanthroline as a catalyst precursor is described. The catalyst precursor was dissolved in an aqueous KOH solution under CO2 pressure prior to the reaction, but was precipitated spontaneously at the end of the reaction. The acidification by the generation of formate caused the transformation from the water-soluble deprotonated form into the water-insoluble protonated form. When the reaction was carried out at 60 degrees C for 20 h using 0.1 M KOH solution under 6 MPa of H2:CO2 (1:1), the catalyst precursor was precipitated spontaneously and the added KOH was consumed completely. The catalyst was recovered by filtration, and the product was obtained by the evaporation of the filtrate. Iridium leaching into the filtrate was found to be 0.11 ppm (<2% of the loaded Ir). The recovered catalyst retained high catalytic activity for four cycles. Consequently, the CO2 conversion using the complex is an environmentally benign process, whose significant features are as follows: (i) catalyst recycling by self-precipitation/filtration, (ii) waste-free process, (iii) the easy isolation of the product, (iv) high efficiency under relatively mild conditions, and (v) aqueous catalysis without the use of organic materials. Furthermore, we have demonstrated the significant roles of the oxyanion generated from the acidic phenolic hydroxyl on the catalyst ligand, which are the catalyst recovery by acid-base equilibrium, as well as the water-solubility by its polarity and the catalyst activation by its electron-donating ability.
No takes yet. Share an insight, caveat, or question.
Himeda et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: